Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHoffmann-La Roche
About this trial
The main purpose of this study is to assess the usability and value of the multiple sclerosis (MS) care management platform in terms of improved monitoring of people with MS (pwMS) in clinical practice.
This is a two-year prospective data collection study with additional data collection at baseline evaluating medical practice over a period of at least one year before the introduction of the MS care management platform.
Eligibility criteria
Qualifiers
Able to comply with the study protocol, including having a smartphone and being able and willing to access the icompanion ms patient app on a regular basis. To use all functionalities of the icompanion ms patient app, the user's smartphone must comply with the minimum system requirements (Android version 5.0 or above, iOS version 11 or above)
Have a valid email address (for registration of icompanion ms)
Have a definite diagnosis of RRMS
Time since MS diagnosis ≥1 year
Disqualifiers
Any contra-indications to using icompanion ms patient app or website, as per the investigator's discretion
Inability to complete an MRI
Currently involved in an interventional trial
Diagnosis of progressive MS (primary progressive multiple sclerosis [PPMS] or secondary progressive multiple sclerosis [SPMS])
Trial design
Treatments tested in this trial
- MS Care Platform (icobrain ms and icompanion ms)
Treatment groups
500 Participants
are divided into 1 treatment groupSponsors and collaborators
Hoffmann-La Roche
Lead sponsor
icometrix
Collaborator
Source ClinicalTrials.gov